Pregled bibliografske jedinice broj: 886625
Comparison Between Clinical Significance of Serum Proinflammatory Protein Interleukin-6 and Classic Tumor Markers Total PSA, Free PSA and Free/Total PSA Prior to Prostate Biopsy
Comparison Between Clinical Significance of Serum Proinflammatory Protein Interleukin-6 and Classic Tumor Markers Total PSA, Free PSA and Free/Total PSA Prior to Prostate Biopsy // Collegium antropologicum, 38 (2014), 1; 147-150 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 886625 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparison Between Clinical Significance of Serum Proinflammatory Protein Interleukin-6 and Classic Tumor Markers Total PSA, Free PSA and Free/Total PSA Prior to Prostate Biopsy
Autori
Miličević, Nevenka ; Mrčela, Milanka ; Lukić, Ivana ; Mandić, Sanja ; Horvat, Vesna ; Galić, Josip
Izvornik
Collegium antropologicum (0350-6134) 38
(2014), 1;
147-150
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
interleukin-6, serum levels, prostate biopsy, prostate-specific antigen, Gleason score
Sažetak
The aim of the study was to clarify whether serum levels of proinflammatory cytokine interleukin-6 (IL-6) could be a useful marker in prostate diseases. Serum IL-6 was determined prior to prostate biopsy procedure in 82 patients with prostate adenocarcinoma (PCa), 25 patients with benign prostatic hyperplasia (BPH), 24 patients with high-grade prostatic intraepithelial neoplasia (PIN) and 17 patients with chronic prostatitis. Serum IL-6 levels were compared with total PSA (tPSA), free PSA (fPSA) and the free/total ratio (f/tPSA) serum levels. Statistically significant difference was not found in serum IL-6 levels among the four groups (p=0.088). However, the patients with poorly differentiated PCa with Gleason score (GS) 4+3=7 and >7 had significantly higher serum IL-6 levels than the patients with moderately differentiated PCa with GS 3+4=7 and <7 (p=0.007). The findings suggest that serum IL-6 level might be a potentially useful marker for poorly differentiated PCa.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
219-0000000-3363 - Imunološki čimbenici razvoja i progresije karcinoma prostate (Galić, Josip, MZOS ) ( CroRIS)
Ustanove:
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek
Profili:
Josip Galić
(autor)
Sanja Mandić
(autor)
Nevenka Miličević
(autor)
Vesna Horvat
(autor)
Milanka Mrčela
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE